Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 62 PS Ratio is 0.09 as of Sep. 20, 2026, which is at its 10-year median of 0.09. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.82 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 122 Medical Distribution companies, Olba DVx Healthcare ranks better than 90.98% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Olba DVx Healthcare's share price is 円1925.00.
Olba DVx Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was 円21,356.71. Hence, Olba DVx Healthcare's PS Ratio for today is 0.09.
Good Sign:
Olba DVx Healthcare Inc stock PS Ratio (=0.09) is close to 3-year low of 0.09.
The historical rank and industry rank for Olba DVx Healthcare's PS Ratio or its related term are showing as below:
TSE:2689'
s PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.09 Max: 0.21
Current: 0.09
During the past 13 years, Olba DVx Healthcare's highest PS Ratio was 0.21. The lowest was 0.05. And the median was 0.09.
TSE:2689's PS Ratio is ranked better than 90.98% of 122
companies
in the Medical Distribution industry
Industry Median: 0.47
vs TSE:2689: 0.09
Olba DVx Healthcare Inc has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Olba DVx Healthcare was 3.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 1.10% per year.
During the past 13 years, Olba DVx Healthcare's highest 3-Year average Revenue per Share Growth Rate was 17.80% per year. The lowest was -4.40% per year. And the median was 4.45% per year.
Olba DVx Healthcare (TSE:2689) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Olba DVx Healthcare PS Ratio Related Terms
Olba DVx Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Olba DVx Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Olba DVx Healthcare's Share Price of today is 円1925.00. Olba DVx Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円21,356.71.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Olba DVx Healthcare (TSE:2689) has a PS Ratio of 0.09 as of Sep. 20, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Olba DVx Healthcare and its competitors. This is near median its historical median of 0.09. Over the past decade, Olba DVx Healthcare's PS Ratio has ranged from 0.05 to 0.21. According to the industry distribution chart, Olba DVx Healthcare ranks #11 out of 122 companies in the Medical Distribution industry, placing it in the top 9%.
Is Olba DVx Healthcare's PS Ratio too high?
Olba DVx Healthcare's current PS Ratio of 0.09 is near median its 10-year median of 0.09. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.21. The Medical Distribution industry median PS Ratio is 0.47. Olba DVx Healthcare's value of 0.09 is 80.9% below this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #11 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #11 out of 122 companies for PS Ratio. This places Olba DVx Healthcare in the top 9% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.47. Olba DVx Healthcare's value of 0.09 is 80.9% below this benchmark. Historically, Olba DVx Healthcare's own PS Ratio has ranged from 0.05 to 0.21 over the past decade. While the company's 10-year median is 0.09 vs. the industry median of 0.47, Olba DVx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.47, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current PS Ratio of 0.09 is 80.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current PS Ratio is 0.09, which is near median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.82, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current PS Ratio is 0.09, which is near median its 10-year median of 0.09 and 80.9% below the Medical Distribution industry median of 0.47. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current PS Ratio is 0.09 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.82.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
PS Ratio: 0.09 (near median its 10-year median of 0.09)
GF Value™: 円2,164.82 vs. price of 円1,925.00 (11.1% below fair value)
Industry Position: 80.9% below the Medical Distribution median (#11 of 122)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
